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R919Journalists and editors seldom 
highlight errors and misjudgements 
by other members of their trade. 
An exception was The Guardian’s 
story on 1 October headed “Media 
accused of scaremongering on cancer 
jab death” and subtitled “Coverage 
causing more harm than good”. The 
case at issue was that of a 14-year 
old Coventry schoolgirl who had died 
a few days previously, after receiving 
human papilloma virus (HPV) vaccine 
to prevent cervical cancer.
The criticism was apposite, as many 
newspaper, radio and TV reporters 
had failed to exercise caution in 
linking the vaccine causally with 
the fatality. Some had also alleged 
that HPV immunisation had been 
suspended around the UK. 
Initial press coverage of the 
incident, even when it mentioned 
uncertainty about the cause of death, 
illustrated the disproportionate 
impact of headlines. “Girl of 14 dies 
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A jab at reality after cervical cancer jab” said a Daily Mirror headline  (29 September) 
occupying more space on the page 
than the report below. “Rogue 
cervical cancer jab fears after girl, 
14, dies. Authorities seize suspect 
vaccine batch,” announced the Daily 
Mail on the same day. 
The Daily Mirror focused on human 
interest (“Everyone was panicking…
It’s really scary”) with one cautionary 
sentence at the very end: “Health 
officials last night stressed that there 
was not yet any evidence that the jab 
was responsible for Natalie’s death”. 
The Guardian was particularly careful, 
reporting a Coventry city council 
official’s view that “no link can be 
made between the death and the 
vaccine until all the facts are known 
and a post mortem takes place.”
 Next day, however, the Daily Mail 
devoted three pages to the story, 
heralded by a front-page banner 
headline ‘Chaos Over Cancer Jab For 
Girls’, and asserting that many health 
trusts throughout the country were 
cancelling vaccinations. There were 
similar assertions elsewhere, coupled 
with reports of anxieties among public 
health authorities that growing alarm 
might adversely affect immunisation campaigns against swine flu and other 
infections. The Daily Mirror produced 
a huge, self-defeating ‘DON’T PANIC’ 
headline, accompanied by a picture of 
tributes to Natalie pinned to a wooden 
cross and comments such as “we 
could be harming a whole generation 
of teenage girls” from a Birmingham 
mother.
Some of the unhelpful coverage 
was by writers ostensibly seeking 
to be helpful. The Independent 
(30 September) provided a mostly 
well-informed page of answers to 
the question “Is the cervical cancer 
vaccine safe, and should girls stop 
taking it?” But a summary box had 
three bullet points in favour and three 
against, implying that the arguments 
were evenly balanced.
Even commentators who should 
have known better were unwilling 
to wait for a post mortem. “The 
sudden death of Coventry schoolgirl 
Natalie Morton after a jab against 
cervical cancer highlights the reality 
that vaccination programmes are 
not without their risks,” wrote Dr 
Richard Halvorsen in the Daily Mail. 
Lambasting “evangelists for mass 
vaccination”, Halvorsen argued that 
“the tragic irony for Natalie was that Protection: One young British girl receives a now routine HPV vaccination. (Photo: Paula Solloway/Alamy.)
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After considerable public and 
parliamentary debate in the UK that 
backed the creation of human–animal 
hybrid embryonic stem cells for 
research purposes, given the shortage 
of human-derived cells, research 
involving them currently appears to 
have been refused funding.
All three projects to develop 
embryonic stem cells from cloned 
embryos created by fusing human cells 
with animal cells have been stalled, 
after publicly-funded research councils 
refused to fund research involving 
the hybrid cells in this year’s grant 
applications.
Two of the projects failed to win 
funds earlier this year and the third 
is now understood to have ended 
when a funding application was 
withdrawn after the research licence 
issued by the Human Fertilisation 
and Embryology Authority (HFEA), 
responsible for such research, expired 
during the summer without being 
renewed, The Independent newspaper 
reported.
Plans to allow British scientists 
to create human–animal embryos 
were approved in 2007 by the HFEA 
after it published its lengthy public 
consultation document. It found that 
the majority of people were ‘at ease’ 
with scientists creating the hybrid 
embryos.
The new Human Fertilisation and 
Embryology Act, which came into force 
last month, was specifically amended 
to permit the creation of cloned 
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(Picture: R. Yorgos Nikas/Science Photo Library.)the injection may have triggered a 
reaction far more lethal than any future 
distant threat of a comparatively rare 
disease”.
The Health Editor of The Times, 
alongside sound advice under the 
headline “There are always risks, but 
this vaccine will save lives”, strongly 
implied that HPV vaccine had caused 
Natalie’s death. “Most experts agree 
that vaccinating against the virus 
that causes cervical cancer is a good 
thing,” he wrote. “It carries risks, 
as fatally shown in Coventry, but 
these are outweighed by benefits. 
Getting this across is far from easy.  
An unknown life saved decades 
down the line does not capture the 
imagination like the spectre on a 
young life lost.”
Equally surprising was an article in 
The Daily Telegraph (30 September) 
by a researcher at the Wellcome 
Trust Centre for the History of 
Medicine, London. “Politicians have 
long known that a life lost today is 
far more emotive than a life saved 
in some hard-to-glimpse future,” 
Mark Honigsbaum wrote. “Never 
mind that history is pitted with 
examples of vaccines that the public 
was falsely assured were safe: the 
experts reason that in every mass 
vaccination there are bound to be 
a few casualties.” Parents were 
entitled to weigh for themselves the 
risks of protecting their daughters 
by HPV vaccination, he said, “but 
there are also other methods, such 
as better screening”. The latter 
comment was particularly inept, 
since regular screening will continue 
for many years and is in no sense an 
alternative to immunisation.
In its article on 1 October, The 
Guardian pointed out that vaccination 
programmes had not been suspended 
(there had simply been a slight delay 
in certain areas receiving vaccine 
supplies), and that a “serious 
underlying medical condition” was 
probably responsible for Natalie 
Morton’s death. Next day, nearly 
all newspapers and radio and TV 
channels carried the pathologist’s 
finding of a “large malignant tumour 
of unknown origin in the heart and 
lungs”.
The immediate furore — though 
probably not underlying public  
anxiety — was at an end.
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